What are the causes, incidence, and associated abnormalities of congenital pseudoarthrosis of the tibia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Congenital Pseudoarthrosis of the Tibia: Causes, Incidence, and Associated Abnormalities

Congenital pseudoarthrosis of the tibia (CPT) is a rare pediatric orthopedic condition characterized by anterolateral bowing of the tibia with high rates of pathologic fracture and non-union, most commonly associated with neurofibromatosis type 1 and requiring combined surgical approaches for optimal outcomes. 1

Incidence and Epidemiology

  • CPT is an extremely rare condition, with very few cases reported per year 2
  • Most commonly presents in the pediatric population under 10 years of age 2
  • Typically manifests as anterolateral bowing of the tibia with high risk of fracture and non-union

Causes and Pathophysiology

Primary Causes:

  • Neurofibromatosis Type 1 (NF1): The most common underlying cause, with approximately 50-60% of CPT cases associated with NF1 1
  • Fibrous hamartoma: Abnormal tissue growth at the pseudarthrosis site that prevents normal bone healing
  • Vascular insufficiency: Poor blood supply to the affected area contributes to impaired healing

Pathological Features:

  • Anterolateral bowing of the tibia that progresses to fracture
  • Sclerotic bone ends with narrowing of the medullary canal
  • Fibrous tissue interposition between bone fragments
  • Biologically and mechanically inferior bone quality, even after healing 3

Associated Abnormalities

Skeletal Abnormalities:

  • Fibular involvement: Persistent fibular pseudarthrosis is present in up to 90% of cases 4
  • Ankle valgus deformity: Common complication affecting 45-50% of patients 4
  • Limb length discrepancy: Mean shortening of 2.6 cm, with some cases experiencing up to 8 cm discrepancy 4
  • Tibial deformities: Anterior or medial bowing ranging from 5-28 degrees 4

Systemic Associations:

  • Neurofibromatosis Type 1: Characterized by café-au-lait spots, neurofibromas, and other manifestations
  • Ankle and foot dysfunction: Limited range of motion and stiffness, particularly when transarticular rods are used 4
  • Growth disturbances: Affecting the tibia and surrounding structures

Complications and Challenges

  • Refracture: The most common and serious complication after primary healing 5

    • Rates vary by treatment technique: 85% for intramedullary rods alone, 81% for Ilizarov alone, 60% for combined techniques, 45% for vascularized fibular grafting, and 22.5% for cross-union 1
    • Can occur up to 18 years after initial fusion 3
  • Non-union: Varies by technique with rates of 16.4% for intramedullary rods alone, 12.3% for Ilizarov alone, 6% for combined techniques, and 7.3% for vascularized fibular grafting 1

  • Ankle stiffness: More common with intramedullary rod fixation techniques 1

  • Progressive deformities: May develop throughout growth period, requiring long-term monitoring 4

Management Considerations

  • Operative management is indicated for all patients over 2 years old (100% consensus agreement) 3, 1
  • Complete excision of the pseudarthrosis site with sufficient autogenous bone grafting is essential (100% consensus agreement) 3, 1
  • Combined fixation approach using both external fixation (Ilizarov) and intramedullary fixation achieves the highest union rates (84% primary union) and lowest complication rates 1
  • Long-term follow-up until skeletal maturity is crucial due to the risk of late refracture 3

Emerging Approaches

  • Cross-union technique: Creates tibiofibular fusion to increase stability, with 100% primary union rate and lower refracture rates (22.5%) 6
  • Adjunctive therapies: Various biological approaches including bone morphogenic proteins and bisphosphonates are being investigated, though current evidence does not strongly support their routine use 3, 1

CPT remains one of the most challenging conditions in pediatric orthopedics, requiring a sophisticated surgical approach and long-term monitoring to address both the primary pathology and associated complications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.